Potent Kratom Derivative Triggers Opioid-Style Withdrawal, Doctors Warn
A case study describes a 43-year-old man who developed opioid-like withdrawal after stopping high-dose 7-OH kratom products, a potent semi-synthetic derivative often marketed as kratom. Tests ruled out other causes, and doctors treated him with buprenorphine/naloxone and supportive care. The report underscores the potency difference between 7-OH and traditional kratom, rising poisoning reports, and the DEA’s tentative scheduling moves, while calling for clearer distinctions between leaf kratom and concentrated 7-OH products and better clinician guidance.
